Metoprolol Tartrate recalls
Metoprolol Tartrate products have been recalled 3 times, most recently on 5 Jun 2024. The recalling company is usually Rubicon Research Private. The most common reason is foreign material.
Total recalls3since 2021
Last 12 months0reported
Class I00% of total
Ongoing1latest 5 Jun 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why metoprolol tartrate is recalled
Companies
Product types
By year
Ongoing metoprolol tartrate recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Metoprolol Tartrate Tablets USP, 25mg recalledMetoprolol Tartrate | Rubicon Research Private | Foreign Material | Nationwide |
All metoprolol tartrate recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Metoprolol Tartrate Tablets USP, 25mg recalledMetoprolol Tartrate | Rubicon Research Private | Foreign Material | Nationwide |
| Drug | CLASS II | Metoprolol Tartrate Tablets, USP 25 mg recalledMetoprolol Tartrate | Rubicon Research Private | Foreign Material | Nationwide |
| Drug | CLASS II | Metoprolol Tartrate Tablets USP 100 mg recalled by Aurobindo Pharma USAMetoprolol Tartrate | Aurobindo Pharma USA | Foreign Material | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.